162,99 €
inkl. MwSt.
Versandkostenfrei*
Versandfertig in 6-10 Tagen
payback
81 °P sammeln
  • Broschiertes Buch

The proposed book is a holistic review of the clinical use of placental substances, amniotic fluid, the umbilical cord and its contents. It is intended to be a unique presentation of the current advances as well as also discussing the future applications of these substances.
Attention is yet to be focused on the widespread clinical use of pregnancy-related biological substances. The aim for this book is to inform clinicians of the use of such materials and increase awareness of their therapeutic benefits. As such, this reference resource will be of great value to hematologists,…mehr

Produktbeschreibung
The proposed book is a holistic review of the clinical use of placental substances, amniotic fluid, the umbilical cord and its contents. It is intended to be a unique presentation of the current advances as well as also discussing the future applications of these substances.

Attention is yet to be focused on the widespread clinical use of pregnancy-related biological substances. The aim for this book is to inform clinicians of the use of such materials and increase awareness of their therapeutic benefits. As such, this reference resource will be of great value to hematologists, rheumatologists, cardiologists, transplant technologists and all involved in regenerative medicine.

Rezensionen
From the reviews:
"This book describes clinical and preclinical research involving the use of the human umbilical cord, amnion, and placenta for regenerative medicine. It contains a wealth of information and new ideas. ... It is written for clinicians and basic science researchers interested in pregnancy and regenerative medicine ... . documents innovative approaches to regenerative medicine using cord blood and other pregnancy-associated substances. Carefully edited, it provides a fascinating snapshot of current research. This is an important topic that is not often addressed." (Bruce A. Fenderson, Doody's Review Service, January, 2012)